Center for the Biology of Chronic Disease (CBCD)

Does Insurance Cover the Shingles Vaccine?; CBCD Reviews a Report

The Affordable Care Act … has recommended the shingles vaccine for those aged 60 or older. (1)


Rochester, NY -- (SBWIRE) -- 09/30/2015 -- "Infected with the varicella zoster virus? The CBCD recommends taking Gene-Eden-VIR." - Greg Bennett, CBCD

Herpes Zoster (HZ), commonly called shingles, is a distinctive syndrome caused by reactivation of the varicella zoster virus (VZV), which also causes chickenpox. VZV is a herpes virus. Many places that offer Zostavax, the shingles vaccine, charge at least $200.00. The CDC says that the vaccine, "is available by prescription from a healthcare professional. It can be given in the doctor's office and pharmacies." (2)

For those who find the the cost hard to afford, the CBCD points out that the vaccine is covered under the Affordable Care Act. "The Affordable Care Act requires private health insurance plans to cover the cost of preventive care based on the recommendation of expert medical bodies such as the US Preventive Services Task Force and the CDC's Advisory Committee on Immunization Practices (known as ACIP). ACIP has recommended the shingles vaccine for those aged 60 or older." (1)

However, the Center reminds the public that also according to the CDC, "There are no long-term studies showing how long the vaccine is effective in 50 to 59 year olds. In adults vaccinated at age 60 years or older, protection from the vaccine decreases within the first 5 years after vaccination." In addition, shingles can develop in anyone that has ever had chickenpox, and at any age. Therefore, the CBCD recommends taking Gene-Eden-VIR against the latent VZV.

Click to learn more about shingles symptoms.

The formula of Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR formula is effective against the herpes family of viruses. Varicella Zoster is a member of the herpes family. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, "individuals infected with the (herpes viruses) … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR." (3) The study authors also wrote that, "we observed a statistically significant decrease in the severity, duration, and frequency of symptoms." (3)

Gene-Eden-VIR can be ordered online on the product website here:

Gene-Eden-VIR is a natural antiviral dietary supplement. Its formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Gene-Eden-VIR is the only natural antiviral product on the market with published clinical studies that support its claims.

The CDC notes that the varicella zoster virus (VZV), which is a herpes virus, causes both chickenpox and shingles. "After a person recovers from chickenpox, the virus stays dormant (inactive) in the body. For reasons that are not fully known, the virus can reactivate years later, causing shingles." (3) Additionally, the CDC adds that "almost 1 out of every 3 people in the United States will develop shingles, also known as zoster or herpes zoster, in their lifetime. There are an estimated 1 million cases of shingles each year in this country. Anyone who has recovered from chickenpox may develop shingles; even children can get shingles. However the risk of shingles increases as you get older. About half of all cases occur in men and women 60 years old or older." (See the CDC, last reviewed on May 1, 2014) (4)

Are there treatments currently on the market, which target the Varicella Zoster Virus (VZV), other than Zostavax?

Yes there are. There are also antiviral drugs, such as Zovirax or Valtrex. However, these medications, when effective, only work to shorten the time of the shingles outbreak. They are ineffective against the latent VZV virus. (4)

Gene-Eden-VIR is a natural remedy designed to help the immune system target latent herpes viruses, including the VZV. (3)

"Although we believe people older than 60 should probably get vaccinated against the VZV, we also recommend taking Gene-Eden-VIR against the latent form of the virus." – Greg Bennett, CBCD

Find us on Facebook here:

Follow us on Twitter here: @HananPolansky

All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

(1) Hiland, A "Shingles vaccine may be covered for those age 60 or older" July 18, 2015

(2) - Shingles (Herpes Zoster) - Vaccination

(3) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.

(4) - "Shingles (Herpes Zoster)" - Prevention & Treatment. Last Reviewed on May 1, 2014.

About The Center for the Biology of Chronic Disease
The Center for the Biology of Chronic Disease (CBCD) is a non-for-profit organization recognized by the IRS as a tax-exempt organization under section 501(c)3 of the U.S. tax code since 2005. The CBCD specializes in researching the biology of foreign DNA.